Consumer News Experimental Drug Helped Alzheimer S Patients In Small Trial

Northwestern scientists develop experimental drug for early Alzheimer's intervention

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease. Read More

Alzheimer’s pill could reduce brain decline in some high-risk patients, trial suggests

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ... Read More

Experimental Drug Slows Alzheimer's Decline, Researchers Report

An experimental drug being tested to see if it can treat Alzheimer’s disease helped slow the inevitable loss of clear thinking and memory that comes with the condition, researchers reported Wednesday. Read More

A new drug could stop Alzheimer’s before memory loss begins

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ... Read More

Experimental drug NU-9 reduces toxic amyloid in early Alzheimer’s

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms. Read More

This Experimental Pill Targets Alzheimer’s Before Symptoms Appear

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A new experimental drug from ... Read More

Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two major trials last month that found an older drug similar to Ozempic had no effect in slowing ... Read More

Novo Nordisk says Alzheimer's trial with older GLP-1 drug fails

Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer’s ... Read More

J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. Jason Mast is a general assignment reporter at ... Read More

Novo Nordisk Alzheimer's Drug Trials Fail in Blow to Weight-Loss Giant

COPENHAGEN (Reuters) -Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the progression of the brain-wasting disease, the firm said ... Read More

A new drug may stop Alzheimer’s before memory loss starts

Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is already extensive. A new experimental drug called NU-9 is challenging that ... Read More